Sponsored Links
| IBio Announces Positive H1N1 Influenza Vaccine Clinical Trial Results |
 |
 |
 |
| Medical News - Flu Cold SARS | |||
|
iBio, Inc. (NYSE AMEX: IBIO) today announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1)... Read more: Flu / Cold / SARS News From Medical News Today
|